Lv1
99 积分 2023-11-11 加入
Monitoring free light chains in serum using mass spectrometry
7天前
已完结
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma
8天前
已完结
Assessment of serum free light chain measurementsin a large Chinese chronic kidney disease cohort: amulticenter real-world study
20天前
已完结
Rapid detection of genetic modifiers of β-thalassemia based on MALDI-TOF MS
1个月前
已完结
Kidney disease in multiple myeloma
1个月前
已完结
Enhanced detection and Characterization of M-proteins in multiple myeloma patients using An Agilent AssayMAP Bravo liquid handling system coupled to an LC-QTOF
2个月前
已完结
Systemic Light Chain Amyloidosis
4个月前
已完结
Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T‐cells
4个月前
已关闭
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma
6个月前
已完结
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma
6个月前
已关闭
皖公网安备34019202002308
